Abiopharma

CLIQ Digital AG: Cliq Digital AG plant Wechsel in das Basic Board des Freiverkehrs an der Frankfurter Wertpapierbörse

Cadrenals Quiet Expansion Play Is Starting to Get Loud

Mineralys Therapeutics’ Phase 3 Launch-HTN Trial of Lorundrostat Recognized in Inaugural Journal of the American Medical Association (JAMA)“Research of the Year” Roundup

Intelligent Bio Solutions Inc. - Intelligent Bio Solutions Inc. Announces Reverse Stock Split

Abbott increases quarterly dividend for 54th consecutive year

Cadrenals Anticoagulation Platform Is Expanding in a $40 Billion Market

Novo Nordisk A/S: More efficacious dose of Wegovy® recommended by the European Medicines Agency can help people with obesity achieve an average of 20.7% weight loss

Actinium Pharmaceuticals Presents New Preclinical Data Demonstrating Potent Anti-Tumor Activity of ATNM-400 Across Multiple Breast Cancer Subtypes Including Hormone Receptor-Positive, Triple-Negative, and Tamoxifen- and HER2 Therapy-Resistant Breast Cancer Models at SABCS 2025

Merck Receives Positive EU CHMP Opinion for Expanded Use of WINREVAIR™ (sotatercept) in Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1 Pulmonary Hypertension)

Cytokinetics Announces Positive CHMP Opinion of MYQORZO® (Aficamten) for the Treatment of Obstructive Hypertrophic Cardiomyopathy